Ambrisentan Tablet, Film Coated
Product Images NDC 69097-386

9 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ambrisentan (NDC 69097-386). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of ambrisentan, showing its molecular arrangement including phenyl groups, methoxy group, carboxyl group, and methyl-substituted azine ring system.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot chart showing the fold change and 90% confidence intervals of various interacting drugs (Cyclosporine, Mycophenolate Mofetil, Ketoconazole, Omeprazole, Rifampin, Ritonavir, Sildenafil, Tacrolimus, Tadalafil, Warfarin) on Ambrisentan pharmacokinetics parameters Cmax and AUC, with corresponding dose adjustment recommendations. The x-axis represents the change relative to Ambrisentan alone.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A forest plot chart illustrating the fold change and 90% confidence intervals in pharmacokinetic parameters Cmax and AUC of various interacting drugs when administered with Ambrisentan. The chart shows drugs including Cyclosporine, Digoxin, Ethinylestradiol, Norethindrone, Mycophenolic acid, Ritonavir, Sildenafil, Desmethylsildenafil, Tadalafil, and Warfarin with respective dose adjustment recommendations, all indicating no dose adjustment required.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
Two line graphs labeled ARIES-1 and ARIES-2 showing distance in meters on the vertical axis and time points Baseline, Week 4, Week 8, and Week 12 on the horizontal axis. Each graph compares Placebo with different doses of Ambrisentan (5 mg and 10 mg in ARIES-1; 2.5 mg and 5 mg in ARIES-2). Data points include error bars illustrating variability at each time point.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
Two Kaplan-Meier event-free survival curves from the ARIES-1 and ARIES-2 studies comparing Ambrisentan versus placebo over 12 weeks. The y-axis represents the percentage event-free, and the x-axis is time in weeks. Ambrisentan groups show higher event-free percentages (97% and 94%) than placebo (89% and 79%), with p-values of 0.030 and 0.005 respectively.*
FDA Label Image

Ambrisentan-tabs-5mg-30s (Ambrisentan Tabs 5mg 30s)

Ambrisentan-tabs-5mg-30s (Ambrisentan Tabs 5mg 30s)
Ambrisentan 5 mg film-coated tablets label from Cipla USA Inc. The label includes dosage instructions indicating each tablet contains 5 mg of ambrisentan, along with storage information and dispensing instructions. It specifies a package size of 30 tablets and provides manufacturer details for Cipla Ltd. in India and Cipla USA Inc. in New Jersey.*
FDA Label Image

Ambrisentan-tabs-5mg-10s (Ambrisentan Tabs 5mg 10s)

Ambrisentan-tabs-5mg-10s (Ambrisentan Tabs 5mg 10s)
Label for Ambrisentan 5 mg film-coated tablets by Cipla USA Inc. The label indicates that each carton contains 10 tablets, each with 5 mg of ambrisentan. The label includes NDC 69097-386-19, barcode, and instructions for authorized dispensers to provide a medication guide.*
FDA Label Image

Ambrisentan-tabs-10mg-30s (Ambrisentan Tabs 10mg 30s)

Ambrisentan-tabs-10mg-30s (Ambrisentan Tabs 10mg 30s)
Ambrisentan 10 mg film-coated tablets label from Cipla USA Inc. The label indicates the product is for prescription use only and contains 30 tablets. It includes dispensing instructions, storage conditions, and manufacturer information for Cipla Ltd., India. The label also features a barcode and the revision date Rev. 4/2024.*
FDA Label Image

Ambrisentan-tabs-10mg-10s (Ambrisentan Tabs 10mg 10s)

Ambrisentan-tabs-10mg-10s (Ambrisentan Tabs 10mg 10s)
Ambrisentan 10 mg film-coated tablets packaging label showing the product name, strength, and quantity of 10 tablets. The label includes the NDC number 69097-387-19, indicates the prescription-only status, and the labeler Cipla USA Inc. The text specifies that each tablet contains 10 mg of ambrisentan and provides instructions for the dispenser regarding the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.